Biểu đồ giá cổ phiếu INM
INM Tài chính
InMed Pharmaceuticals Inc
$1.72
-0.57%
$-0.01
Khi đóng cửa: May 22, 16:00:00 GMT-4
$1.66
-3.48%
$-0.06
Phiên sau giờ: May 22, 20:00:00 GMT-4
Quay lại
InMed Pharmaceuticals Inc (INM) Tài chính
Thống kê chính
Giá đóng cửa trước
$1.73
Giá mở cửa
$1.77
Phạm vi ngày
$1.58 - $1.98
Phạm vi 52 tuần
$0.575 - $7.98
Khối lượng
660.3K
Khối lượng trung bình
1.1M
Tỷ suất cổ tức
--
EPS (TTM)
-4.83
Vốn hóa thị trường
$5.4M
INM là gì?
InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-06-21. The firm develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
